Immix Biopharma (IMMX) Interest Expenses (2021 - 2022)

Immix Biopharma's (IMMX) quarterly Interest Expenses came in at $109.0 in Q2 2022, down 99.8% year-on-year from $53865.0 in Q2 2021, and down 71.91% quarter-over-quarter from $388.0 in Q1 2022.

Immix Biopharma (IMMX) Interest Expenses (2021 - 2022) Analysis & Trends

Immix Biopharma has disclosed Interest Expenses across 2 years of filings, most recently posting $109.0 for Q2 2022.

  • Interest Expenses for Q2 2022 came in at $109.0, down 99.8% year-over-year; the trailing twelve-month figure through Mar 2023 was $109.0 (down 99.93% YoY), and the FY2022 annual result was $497.0, down 99.72% from the prior year.
  • Interest Expenses came in at $109.0 for Q2 2022 at Immix Biopharma, down from $388.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $53937.0 in Q3 2021 to a low of $109.0 in Q2 2022.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -5.50 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 61,000.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -332,000.00
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -2,753.00
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -5.58 Mn
10 Immix Biopharma 467.59 Mn 467.59 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 109.00
Jun 30, 2022 109.00
Mar 31, 2022 388.00
Mar 31, 2022 388.00
Dec 31, 2021 44,507.00
Dec 31, 2021 44,507.00
Sep 30, 2021 53,937.00
Sep 30, 2021 53,937.00
Jun 30, 2021 53,865.00
Jun 30, 2021 53,865.00
Mar 31, 2021 27,544.00
Mar 31, 2021 27,544.00